Observational Study on the Prophylactic Use of Curosurf in Neonatal Respiratory Distress Syndrome (RDS)
Completed
- Conditions
- Respiratory Distress Syndrome, Newborn
- Registration Number
- NCT01102543
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Brief Summary
The aim of Alizé is to describe a population of premature babies (gestational age (GA) \< 32 weeks) in real life situation and the management of RDS.
- Detailed Description
Description includes gestational age, birth clinical characteristics in particular the respiratory function, evaluation of the mother prenatal corticosteroids treatment in prophylaxis of RDS, mother medical and obstetric history, premature babies care in the delivery room with a special focus on the Curosurf use: prophylactic or curative use / other surfactant / no surfactant. A special focus is on the Prophylactic use.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 972
Inclusion Criteria
- during the study, each neonatologist will have to include all the babies born with a gestational age < 32 GA
Exclusion Criteria
- gestational age > 32 GA
- No consent to the data collection by one of the parents
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Laboratoire Chiesi S.A.
🇫🇷Courbevoie, France